A glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin α(IIb)β3

Thrombosis and Haemostasis

Volumn 80, Issue 5, 1998, Pages 735-742

  Tomiyama, Yoshiaki ^a   Shiraga, Masamichi ^a   Kinoshita, Seiji ^c   Ambo, Hironobu ^d   Kurata, Yoshiyuki ^b   Matsuzawa, Yuji ^a   Kunicki, Thomas J ^e  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c Higashi Osaka Munic Ctrl Hospital   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHYMOTRYPSIN; INTEGRIN; LIGAND; MONOCLONAL ANTIBODY; MYOSIN LIGHT CHAIN; PLECKSTRIN; PROTEIN SUBUNIT; THROMBIN;

ADULT; ARTICLE; BLEEDING; CALCIUM BLOOD LEVEL; CASE REPORT; CYTOPLASM; FEMALE; GLANZMANN DISEASE; HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; THROMBOCYTE AGGREGATION;

EID: 0031773629     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615351     Document Type: Article

References (49)

1. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
2. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
3. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-43.
4. Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood 1993; 81: 2827-43.
5. Faull RJ, Ginsberg MH. Dynamic regulation of integrins. Stem Cells 1995; 13: 38-46.
6. 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem 1991; 266: 17106-11.
7. Ginsberg MH, Frelinger AL, Lam SC-T, Forsyth J, McMillan R, Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformationspecific monoclonal antibodies. Blood 1990; 76: 2017-23.
8. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75: 1383-95.
9. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-59.
10. 3. J Biol Chem 1993; 268: 23087-92.
11. Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989; 74: 1181-95.
12. Blockmans D, Deckmyn H, Vermylen J. Platelet activation. Blood Reviews 1995; 9: 143-56.
13. 3 integrins in hemostasis and vascular biology. Thromb Haemost 1995; 74: 149-55.
14. Bray PF. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization. Thromb Haemost 1994; 72: 492-502.
15. Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol 1994; 31: 301-11.
16. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 1990; 249: 915-8.
17. 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem 1992; 267: 3789-94.
18. Lanza F, Stierlé A, Fournier D, Morales M, André G, Nurden AT, Cazenave J-P. A new variant of Glanzmann's thrombasthenia (Strasbourg I): platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg → 214Trp mutation. J Clin Invest 1992; 89: 1995-2004.
19. Honda S, Tomiyama Y, Shiraga M, Tadokoro S, Takamatsu J, Saito H, Kurata Y, Matsuzawa Y. A two-amino acid insertion in the Cys146-Cys167 loop of the aIIb subunit is associated with a variant of Glanzmann thrombasthenia: critical role of Asp 163 in ligand binding. J Clin Invest 1998; 102: 1183-92.
20. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10169-73.
21. Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kinoshita S, Kanayama Y, Kurata Y, Matsuzawa Y. Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombasthenia. Br J Haematol 1994; 87: 119-24.
22. Tomiyama Y, Tsubakio T, Piotrowicz RS, Kurata Y, Loftus JC, Kunicki TJ. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood 1992; 79: 2303-12.
23. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ. Interaction of AP2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-6.
24. 3. J Biol Chem 1992; 267: 18085-92.
25. 3 (GPIIb-IIIa) receptor function. J Biol Chem 1994; 269: 20913-9.
26. 3 subunit. J Biol Chem 1995; 270: 11947-54.
27. Loftus JC, Plow EF, Frelinger AL III, D'Souza SE, Dixon D, Lacy J, Sorge J, Ginsberg MH. Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci USA 1987; 84: 7114-8.
28. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-6.
29. 2+ exchanger. Blood 1996; 88: 2594-602.
30. Tomiyama Y, Kurata Y, Mizutani H, Kanakura Y, Tsubakio T, Yonezawa T, Tarui S. Platelet glycoprotein IIb as a target antigen in two patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 1987; 66: 535-8.
31. 3. Blood 1998, in press.
32. Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y. Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann's thrombasthenia. Thromb Haemost 1995; 73: 756-62.
33. 3 deficiency in Glanzmann thrombasthenia. Blood 1998, in press.
34. Tanoue K, Hasegawa S, Yamaguchi A, Yamamoto N, Yamazaki H. A new variant of thrombasthenia with abnormally glycosylated GPIIb/IIIa. Thromb Research 1987; 47: 323-33.
35. 3 integrin chain:the CA/TU human platelet alloantigen system. Blood 1993; 82: 3386-91.
36. Niessner H, Clemetson KJ, Panzer S, Mueller-Eckhardt C, Santoso S, Bettelheim P. Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies. Blood 1986; 68: 571-6.
37. 3 (platelet glycoprotein IIb-IIIa). Blood 1994; 84: 1857-65.
38. Baker EK, Tozer EC, Pfaff M, Shattil S, Loftus JC, Ginsberg MH. A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro. Proc Natl Acad Sci USA 1997; 94: 1973-8.
39. Shattil SJ, Brass LF. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987; 262: 992-1000.
40. Pulcinelli FM, Ashby B, Gazzaniga PP, Daniel JL. Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets. FEBS lett 1995; 364: 87-90.
41. Gabbeta J, Yang X, Sun L, McLane MA, Niewiarowski S, Rao AK. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood 1996; 87: 1368-76.
42. Kornecki E, Cooper BA, Ehrlich YH. Identification of a unique type of thrombopathy of human platelets: defect in the exposure of active fibrinogen receptors in a patient with Friedreich's ataxia. J Lab Clin Med 1988; 111: 618-26.
43. 3 subunit. J Cell Biol 1995; 131: 807-16.
44. 3 integrin cytoplasmic tail. J Cell Biol 1997; 137: 1433-43.
45. Zhang Z, Vuori K, Wang H-G, Reed JC, Ruoslahti E. Integrin activation by R-ras. Cell 1996; 85: 61-9.
46. Greenberg JP, Packham MA, Guccione MA, Harfenist EJ, Orr JL, Kinlough-Rathbone RL, Perry DW, Mustard LF. The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood 1979; 54: 753-65.
47. Niewiarowski S, Budzynski AZ, Morinelli TA, Brudzynski TM, Stewart GJ. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem 1981; 256: 917-25.
48. Rink TJ, Sage SO. Calcium signaling in human platelets. Annu Rev Physiol 1990; 52: 431-49.
49. 2+ channels in human platelets. J Biol Chem 1992; 267: 17078-81.